Cassie Jung
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Cassie Jung
Cassie Jung is recorded as COO at Aquestive Therapeutics, Inc. (AQST). Aquestive Therapeutics, Inc. reported in an 8-K filed June 6, 2024 that Cassie Jung was appointed Chief Operating Officer, effective June 3, 2024.
“Aquestive Therapeutics, Inc. (the "Company") has promoted Cassie Jung, 45, to Chief Operating Officer, effective June 3, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Aquestive Therapeutics, Inc. (AQST)
Proxy statement
Start not stated–2024-04-26
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aquestive Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Daniel Barber CEO, Board Member
- Gregory B. Brown Chairman
- John S. Cochran Chairman
- A. Ernest Toth CFO
- A. Ernest Toth, Jr. CFO
- Thomas A. Zalewski General Counsel
- Abigail L. Jenkins Board Member
- Julie Krop Board Member
- Marco Taglietti Board Member
- Richard J. Daly Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.